C l i n i c a l m e d i c i n e

HIGHLIGHTS

• who: Omicron variant surge and colleagues from the DepartmentUniversity Hospital Medicine, Baltimore, Maryland, USA have published the research work: C L I N I C A L M E D I C I N E, in the Journal: (JOURNAL) of February/17,/2022
• what: The authors determined antibody and T_cell responses following breakthrough infections in 18 individuals who had received a booster mRNA_vaccine (referred hereafter as breakthrough VRs) during the Omicron variant surge. In the studies described above, the authors compared responses from breakthrough VRs at a median of 11 days after symptom onset with . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.